Commission on Human Medicines
gov.uk
Imported from official source
Commission on Human Medicines — publications from its own official source.
Publications 20
-
Professor Richard FitzGerald appointed to the Commission on Human Medicines
The appointment will involve a time commitment of approximately 22 days per year including 11 meetings. Remuneration for the roles will be at a rate of £325 per meeting.
-
Research: CHM evaluation: Transient embryonic hypoxia and teratogenicity with HPTs
MHRA assessment of transient embryonic hypoxia and teratogenicity in relation to oral hormone pregnancy tests (HPTs), as considered by the Commission on Human Medicines (CHM).
-
Professor Claire Stewart appointed to the Commission on Human Medicines as three members reappointed
The appointment will involve a time commitment of 22 days per year. Remuneration for the role will be at a rate of £325 per attendance and preparation for meetings.
-
Independent report: CHM's report on proposed changes to the availability of puberty blockers
Independent report by the Commission on Human Medicines on the safety implications of a proposal to restrict the availability of puberty blockers for under 18s.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 7 December 2020 to 3 January 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 7 December 2020 to 3 January 2021.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 12 April 2021 to 4 May 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 12 April 2021 to 4 May 2021.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 25 August 2020 to 28 November 2020
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 August 2020 to 28 November 2020.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 25 February 2021 to 6 April 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 February 2021 to 6 April 2021.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 13 January 2021 to 15 February 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 13 January 2021 to 15 February 2021.
-
Transparency data: Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 10 May 2021 to 25 May 2021
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 10 May 2021 to 25 May 2021.
-
Professor Sir Munir Pirmohamed appointed chair of CHM for another four years as three commissioners reappointed
The appointment will involve a time commitment of 33 days per year. Remuneration for the role will be at a rate of £500 per attendance and preparation for meetings.
-
Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2023
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
-
Research: Report of the Commission on Human Medicines Isotretinoin Implementation Advisory Expert Working Group
Report of the Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccut...
-
Research: Use of UK plasma for the manufacture of albumins and vCJD risk
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
-
Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2022
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
-
Research: Report of the Commission on Human Medicines Isotretinoin Expert Working Group
Report of the Commission on Human Medicines (CHM) Isotretinoin Expert Working Group and plain-language summary of the recommendations.
-
Nine new commissioners appointed to the Commission on Human Medicines
Nine new commissioners have been appointed to the Commission on Human Medicines to serve for four years, in accordance with the Cabinet Office Code of Governance for Public Appointments.
-
Corporate report: Human Medicines Regulations 2012 Advisory Bodies Annual Report 2021
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
-
Consultation on a new Code of Practice for the Expert Advisory Committees
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are ba...
-
Life-saving adrenaline auto-injectors could become available in public places
The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come...